drugset / Trial / NCT02481505

Spinal Anaesthesia With Chloroprocaine HCl 1% for Elective Lower Limb Procedures of Short Duration.

NCT02481505 ↗

Phase 2 Completed 45 enrolled Sintetica SA Cross S.A. · collab
RandomizedParallel-groupSingle-blindOther

Summary

This study evaluate the effect of 3 doses of Chloroprocaine HCl 1% (30, 40 and 50 mg) for spinal anaesthesia in adult patients undergoing short duration elective surgery of the lower limb. Patients undergoing elective short-duration lower limb surgery will be randomised into 3 treatment groups (15 patients per group) to receive one of the 3 single doses of Chloroprocaine HCl 1%, i.e. either D1, D2 or D3, via intrathecal injection.

Timeline

Start
2015-06
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroprocaine HCl 1% Unknown 30 mg Intrathecal
Subject Chloroprocaine HCl 1% Unknown 40 mg Intrathecal
Subject Chloroprocaine HCl 1% Unknown 50 mg Intrathecal

Indications

No indication recorded.